Organogenesis Ownership | Who Owns Organogenesis?


OverviewForecastRevenueFinancialsChartTranscripts

Organogenesis Ownership Summary


Organogenesis is owned by 47.90% institutional investors, 43.44% insiders, and 8.65% retail investors. Morgan stanley is the largest institutional shareholder, holding 8.78% of ORGO shares. Xtrackers S&P 500 2xLev Dly Swap ETF 1C is the top mutual fund, with 1.82% of its assets in Organogenesis shares.

ORGO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOrganogenesis47.90%43.44%8.65%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.23%10.67%55.10%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Morgan stanley11.58M8.78%$32.41M
Soleus capital management11.52M8.74%$32.25M
Blackrock5.09M3.86%$14.24M
Vanguard group3.56M2.70%$9.98M
Acadian asset management3.07M2.33%$8.61M
Assenagon asset management2.95M2.23%$9.44M
Deutsche bank ag\2.50M1.90%$7.01M
Aqr capital management2.27M1.72%$6.35M
Dimensional fund advisors lp2.04M1.54%$5.70M
Geode capital management1.75M1.32%$4.89M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Soleus capital management11.52M2.84%$32.25M
Wealth dimensions group407.96K0.33%$1.14M
Advantage alpha capital partners lp358.45K0.22%$1.00M
Kent lake capital151.91K0.19%$425.33K
Gsa capital partners llp884.72K0.17%$2.48M
Ajovista15.51K0.13%$43.44K
Sentinel trust co lba149.03K0.05%$417.00K
State of wyoming95.01K0.04%$266.02K
Capital square20.30K0.04%$61.31K
Acadian asset management3.07M0.03%$8.61M

Top Buyers

HolderShares% AssetsChange
Soleus capital management11.52M2.84%1.95M
Assenagon asset management2.95M0.02%1.04M
Aqr capital management2.27M0.01%986.13K
Norges bank482.20K0.00%482.20K
Gsa capital partners llp884.72K0.17%353.50K

Top Sellers

HolderShares% AssetsChange
Healthcare of ontario pension plan trust fund---649.90K
Thompson siegel & walmsley---429.18K
Hrt financial lp---318.94K
State of wisconsin investment board---229.30K
Ameriprise financial132.47K0.00%-223.98K

New Positions

HolderShares% AssetsChangeValue
Norges bank482.20K0.00%482.20K$1.35M
Kent lake capital151.91K0.19%151.91K$425.33K
Corebridge financial38.84K0.00%38.84K$108.74K
Mirae asset global etfs35.79K0.00%35.79K$100.22K
Cerity partners29.95K0.00%29.95K$83.87K

Sold Out

HolderChange
Assetmark-4.00
Northwestern mutual wealth management-10.00
Nelson, van denburg & campbell wealth management group-13.00
Old point trust & financial services n a-250.00
Allspring global investments-570.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024112-4.27%63,509,8320.99%472.11%53-26.39%3930.00%
Jun 30, 2024117-6.40%62,887,60411.28%472.56%7212.50%30-31.82%
Mar 31, 202412513.64%56,511,096-2.87%432.20%6418.52%4422.22%
Dec 31, 20231101.85%58,178,34411.66%442.81%5412.50%36-2.70%
Sep 30, 2023108-6.09%52,101,4450.61%392.54%48-4.00%37-11.90%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Xtrackers S&P 500 2xLev Dly Swap ETF 1C2.41M1.82%-
Xtrackers S&P Global Infra Swap ETF 1C2.08M1.66%2.08M
iShares Russell 2000 ETF1.94M1.55%-7.47K
Vanguard Total Stock Mkt Idx Inv1.46M1.16%-
Vanguard Institutional Extnd Mkt Idx Tr1.10M0.87%-
Fidelity Small Cap Index735.33K0.58%-527.00
iShares Russell 2000 Value ETF605.50K0.48%-16.93K
DFA US Small Cap Value I467.57K0.37%33.13K
State St Russell Sm/Mid Cp® Indx NL Cl C435.82K0.35%-7.40K
DFA US Targeted Value I423.19K0.34%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 16, 2024Gillheeney Gary S. President and CEOSell$19.49K
Dec 13, 2024Gillheeney Gary S. President and CEOSell$186.87K
Dec 11, 2024Gillheeney Gary S. President and CEOSell$573.11K
Dec 12, 2024Gillheeney Gary S. President and CEOSell$153.92K
Dec 10, 2024Gillheeney Gary S. President and CEOSell$213.03K

Insider Transactions Trends


DateBuySell
2024 Q4-7
2024 Q3--
2024 Q2--
2024 Q1-4
2023 Q2-2

ORGO Ownership FAQ


Who Owns Organogenesis?

Organogenesis shareholders are primarily institutional investors at 47.90%, followed by 43.44% insiders and 8.66% retail investors. The average institutional ownership in Organogenesis's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.23%, which Organogenesis exceeds.

Who owns the most shares of Organogenesis?

Organogenesis’s largest shareholders are Morgan stanley (11.58M shares, 8.78%), Soleus capital management (11.52M shares, 8.74%), and Blackrock (5.09M shares, 3.86%). Together, they hold 21.37% of Organogenesis’s total shares outstanding.

Does Blackrock own Organogenesis?

Yes, BlackRock owns 3.86% of Organogenesis, totaling 5.09M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.24M$. In the last quarter, BlackRock increased its holdings by 112.84K shares, a 2.27% change.

Who is Organogenesis’s biggest shareholder by percentage of total assets invested?

Soleus capital management is Organogenesis’s biggest shareholder by percentage of total assets invested, with 2.84% of its assets in 11.52M Organogenesis shares, valued at 32.25M$.

Who is the top mutual fund holder of Organogenesis shares?

Xtrackers S&P 500 2xLev Dly Swap ETF 1C is the top mutual fund holder of Organogenesis shares, with 1.82% of its total shares outstanding invested in 2.41M Organogenesis shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools